You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


Biogen Idec readies its next move

Company’s hopes for market dominance hinge on approval of oral MS treatment

WESTON — There’s been no shortage of drama at Biogen Idec Inc. in recent years.

The area’s largest independent biotech survived a proxy battle, replaced its top executive, and moved its headquarters here from Cambridge only to announce plans to return. The company also pulled a powerful multiple sclerosis treatment from the market, relaunched it, and turned the drug into a blockbuster that is ringing up annual sales of more than $1 billion.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week